Skip to main content

New Bard Ventralex ST Implant Lawsuit Filed

New Bard Ventralex ST Implant Lawsuit Filed

New Bard Ventralex ST Implant Lawsuit Filed

Introduction

C.R. Bard and Davol will have to defend yet another product liability lawsuit filed in the U.S. District Court, Western District of Missouri by a Missouri woman who alleges she faced adverse reactions due to the Ventralex ST hernia patch. The woman had to undergo a revision surgery after the failure of the device which was implanted in 2013, which would further require multiple surgeries for correction.

Another Ventralex Hernia Patch lawsuit claiming negligence, design defect, manufacturing defect, failure to warn, and breach of warranty and violation of consumer protection laws was filed by a man from California, and his wife claimed loss of consortium in New Jersey federal court. The man suffered internal injuries after the mesh entangled in his body and states the mesh requires a surgical removal, but cannot be removed.

Comments

I have jj bard ventrlyx st patch (2014) it came with staph and strep.fda voluntary recall in 2012. No informed consent.
Texas lawsuit jan 2016.was supposed to get 70 grand. Texas lawyer kept $ and went to work for bard

-
Susan Falsetti…

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Talcum Powder Cancer Settlement Talks Begin Sept. 4

Categories: Talcum

Representatives of Johnson & Johnson (J&J) and attorneys for tens of thousands of plaintiffs involved in talcum powder lawsuits are scheduled to meet in September 2025 in an…

Tepezza Hearing Loss Trials Delayed Until Aug 2026

Categories: Tepezza

A series of Tepezza hearing loss lawsuits, which were expected to go before juries next year, will now be delayed. The U.S. District Judge overseeing the multidistrict…

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!